Abbott stock rises after CEO Robert Ford buys $2 million in shares — what ABT investors watch next
Abbott Laboratories shares rose about 1.3% to close near $108.77 in after-hours trading Monday after CEO Robert B. Ford’s family trust bought 18,800 shares at roughly $107 each, according to an SEC filing. The move follows a sharp selloff last week after Abbott missed revenue estimates and issued a weak earnings outlook.
